Page 2 - Membrane Type News Today

Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) insider Nigel Crockett sold 2,643 shares of the firm’s stock in a transaction on Wednesday, January 3rd. The shares were sold at an average price of $17.50, for a total value of $46,252.50. Following the sale, the insider now directly owns 48,716 shares in the company, valued […]

Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) saw a large drop in short interest in the month of November. As of November 15th, there was short interest totalling 4,000,000 shares, a drop of 8.5% from the October 31st total of 4,370,000 shares. Based on an average daily trading volume, of 434,300 shares, the short-interest […]

/PRNewswire/ -- The "China Membrane Bioreactor Market, Competition, Forecast & Opportunities, 2028" report has been added to ResearchAndMarkets.coms offering....

FABR (Film Bulk Acoustic Resonator) Filter Market Analysis and Future Prospects for 2030

Cantor Fitzgerald restated their overweight rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a research note released on Wednesday, Benzinga reports. Cantor Fitzgerald currently has a $65.00 target price on the stock. A number of other brokerages have also issued reports on BCYC. B. Riley raised Bicycle Therapeutics from a neutral rating […]

Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) was the recipient of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 4,430,000 shares, a drop of 7.3% from the September 30th total of 4,780,000 shares. Based on an average daily volume of 349,000 shares, […]

Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven brokerages that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average […]

Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report)’s share price was down 4.6% during trading on Friday . The stock traded as low as $20.45 and last traded at $20.55. Approximately 49,104 shares traded hands during trading, a decline of 83% from the average daily volume of 284,889 shares. The stock had previously closed at […]

Several analysts have recently updated their ratings and price targets for Bicycle Therapeutics (NASDAQ: BCYC): 9/12/2023 – Bicycle Therapeutics had its “market outperform” rating reaffirmed by analysts at JMP Securities. They now have a $44.00 price target on the stock. 9/12/2023 – Bicycle Therapeutics had its “buy” rating reaffirmed by analysts at Needham & Company […]

B. Riley upgraded shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) from a neutral rating to a buy rating in a report published on Monday, MarketBeat.com reports. B. Riley currently has $33.00 price objective on the stock. Several other analysts have also recently commented on BCYC. HC Wainwright reiterated a buy rating and set a […]